Effect of 26 week magnetic field exposures in a DMBA initiation–promotion mammary gland model in Sprague–Dawley rats
Authors:
- Gary A. BoormanGBGary A. Boorman
- James R. HaileyJHJames R. Hailey
- Robert C. SillsRSRobert C. Sills
- Joseph K. HasemanJHJoseph K. Haseman
Open Access
- 1 May 1999
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 20 (5) , 899-904
Abstract
Several studies have suggested that exposure to 50 Hz magnetic fields promote chemically induced breast cancer in rats. Groups of 100 female Sprague–Dawley rats were initiated with a single 10 mg gavage dose of 7,12-dimethylbenz[a]anthracene (DMBA) at 50 days of age followed by exposure to ambient fields (sham exposed), 50 Hz magnetic fields at either 1 or 5 Gauss (G) field intensity or 60 Hz fields at 1 G for 18.5 h/day, 7 days/week for 26 weeks. A vehicle control group without DMBA was included. Rats were palpated weekly for the presence of tumors. There was no effect of magnetic field exposure on body weight gains or the time of appearance of mammary tumors. At the end of 26 weeks, the animals were killed and the mammary tumors counted and measured. Mammary gland masses found grossly were examined histologically. The mammary gland carcinoma incidence was 96, 90, 95 and 85% (P < 0.05, decrease) for the DMBA controls, 1 G 50 Hz, 5 G 50 Hz and 1 G 60 Hz groups, respectively. The total numbers of carcinomas were 649, 494 (P < 0.05, decrease), 547 and 433 (P < 0.05, decrease) for the DMBA controls, 1 G 50 Hz, 5 G 50 Hz and 1 G 60 Hz groups, respectively. The number of fibroadenomas varied from 276 to 319, with the lowest number in the 1 G 60 Hz exposure group. Measurement of the tumors revealed no difference in tumor size between groups. In this breast cancer initiation–promotion study in female Sprague–Dawley rats, there was no evidence that 50 or 60 Hz magnetic fields promoted breast cancer under the conditions of this assay. This study does not support the hypothesis that magnetic field exposure can promote breast cancer in this rat model.Keywords
This publication has 24 references indexed in Scilit:
- ACCELERATION OF MAMMARY TUMORIGENESIS BY EXPOSURE OF 7,12-DIMETHYLBENZ\[a]ANTHRACENE-TREATED FEMALE RATS IN A 50-Hz, 100-muT MAGNETIC FIELD: REPLICATION STUDYJournal of Toxicology and Environmental Health, Part A, 1998
- Exposure of DMBA-treated female rats in a 50-Hz, 50 μTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activationCarcinogenesis, 1996
- In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBACancer Letters, 1995
- Effects of static and time‐varying (50‐Hz) magnetic fields on reproduction and fetal development in ratsTeratology, 1994
- Effects of Weak Alternating Magnetic Fields on Nocturnal Melatonin Production and Mammary Carcinogenesis in RatsOncology, 1994
- Animal studies on the role of 50/60-hertz magnetic fields in carcinogenesisLife Sciences, 1994
- Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic fieldCancer Letters, 1993
- Effects of magnetic fields on mammary tumor development induced by 7, 12‐dimethylbenz(a)anthracene in ratsBioelectromagnetics, 1993
- Electromagnetic field exposure and male breast cancerThe Lancet, 1991
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955